Xiaohan Lu a , b , c , 1 , Fei Wang c , a , b , 1 , Chuanming Xu c , Sunny Soodvilai a , b , Kexin Peng a , b , c , Jiahui Su c , Long Zhao a , b , Kevin T. Yang a , b , Yumei Feng d , e , Shu-Feng Zhou f , Jan-Åke Gustafsson g , 2 , and ... PNAS, 4 weeks ago
Yang Zhao a , b , c , d , Jia-Wei Tang a , Zhi Yang a , Yi-Bin Cao a , e , Ji-Long Ren a , Yuval Ben-Abu f , Kexin Li d , g , Xue-Qun Chen a , b , c , 1 , Ji-Zeng Du a , b , c , 1 , and Eviatar Nevo d , 1 a Division of Neurobiology and ...PNAS, 2 months ago
Brookings Institute, Washington D.C. Mr. Chair, Distinguished Guests, Ladies and Gentlemen, It's a great honor to be invited to this special event. As one of the most important engagement groups of G20, T20 is such an effective platform ...China Embassy, 1 week ago
EFFICACY AND SAFETY OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 INHIBITORS TREATMENT IN FAMILIAL HYPERCHOLESTEROLEMIA: A COMPREHENSIVE META-ANALYSIS OF ALL RANDOMIZED CLINICAL TRIALS
More from: Journal of the American College of Cardiology, European Heart Journal...and 2 other sources
Minister Li Kexin Attended "Chinese Cultural Night" at the Meridian International Center 2016/02/05 Red lanterns and Chinese knots made the Meridian House festive in the evening of Feb. 4th, when Chinese Cultural Night co-hosted by the ...China Embassy, 2 months ago
Pfizer has completed patient enrollment in the global SPIRE-2 cardiovascular outcome trial for its investigational agent bococizumab. SPIRE-2 is evaluating the efficacy and safety of bococizumab compared to placebo in reducing the risk of major ...Pharmaceutical Business Review, 1 day ago Pfizer Announces Patient Enrollment Completion In SPIRE-2 Cardiovascular Trial Quotenet.com, 2 days ago Bococizumab SPIRE-2 Cardiovascular Outcome Study Fully Enrolled Wallstreet Online, 2 days ago Pfizer completes patient enrolment in bococizumab SPIRE-2 cardiovascular outcome study Drug Development Technology, 1 day ago
Singapore: Japanese pharma giant Amgen Astellas BioPharma and Astellas Pharma recently announced the launch of their product- Repatha inhibitor syringe in the Japanese market. The genetically recombined injection that consists of a proprotein ...Bio Spectrum Asia, 14 hours ago Amgen Astellas launches Repatha in Japan25-04-2016 Pharma Letter, 3 days ago
1 * , Devon C Christian 1 , Jessica Minnier 2 , Deanna Plubell 1 , Michael D Shapiro 1 , Calvin Yeang 3 , Ilaria Giunzioni 1 , Mikaël Croyal 4 , P B Duell 1 , Gilles Lambert 5 , Sotirios Tsimikas 3 and Sergio Fazio 1 1 Knight ...Circulation Research, 17 hours ago
Figure1 Via downregulation of the lipoprotein lipase (LPL) adapter molecule GPIHP-1 and upregulation of the LPL inhibitor molecule ANGPTL4, nephrotic syndrome results in a marked decrease in abundance and activity in muscle and adipose tissue.Kidney International, 2 days ago
Findings from University of Kentucky Has Provided New Data on Cardiovascular Research (Defining the Role of PCSK9 Inhibitors in the Treatment of...
Findings from University of Kentucky Has Provided New Data on Cardiovascular Research (Defining the Role of PCSK9 Inhibitors in the Treatment of Hyperlipidemia) By a News Reporter-Staff News Editor at Clinical Trials Week Researchers detail new ...Pharmacy Choice, 3 days ago Findings from Hartford Hospital Has Provided New Data on Heart Disease [Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant... Pharmacy Choice, 3 days ago Findings from University Hospital Provides New Data on Acute Coronary Syndrome (Prognostic value of PCSK9 levels in patients with acute coronary... Pharmacy Choice, 1 month ago
on your WebpageAdd Widget >Get your members hooked!